Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice

被引:127
作者
Das, Rituparna [1 ]
Strowig, Till [2 ,6 ]
Verma, Rakesh [1 ]
Koduru, Srinivas [1 ]
Hafemann, Anja [2 ]
Hopf, Stephanie [2 ]
Kocoglu, Mehmet H. [1 ]
Borsotti, Chiara [3 ]
Zhang, Lin [1 ]
Branagan, Andrew [1 ,2 ]
Eynon, Elizabeth [2 ]
Manz, Markus G. [3 ]
Flavell, Richard A. [2 ,4 ]
Dhodapkar, Madhav V. [1 ,2 ,5 ]
机构
[1] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA
[3] Univ Zurich Hosp, Div Hematol, Zurich, Switzerland
[4] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA
[5] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA
[6] Helmholtz Ctr Infect Res, Braunschweig, Germany
基金
美国国家卫生研究院;
关键词
MULTIPLE-MYELOMA CELLS; MONOCLONAL GAMMOPATHY; DISEASE PROGRESSION; MODEL; INTERLEUKIN-6; HETEROGENEITY; MEDICINE; FREQUENT; IMMUNITY;
D O I
10.1038/nm.4202
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most human cancers, including myeloma, are preceded by a precursor state. There is an unmet need for in vivo models to study the interaction of human preneoplastic cells in the bone marrow microenvironment with non-malignant cells. Here, we genetically humanized mice to permit the growth of primary human preneoplastic and malignant plasma cells together with non-malignant cells in vivo. Growth was largely restricted to the bone marrow, mirroring the pattern in patients with myeloma. Xenografts captured the genomic complexity of parental tumors and revealed additional somatic changes. Moreover, xenografts from patients with preneoplastic gammopathy showed progressive growth, suggesting that the clinical stability of these lesions may in part be due to growth controls extrinsic to tumor cells. These data demonstrate a new approach to investigate the entire spectrum of human plasma cell neoplasia and illustrate the utility of humanized models for understanding the functional diversity of human tumors.
引用
收藏
页码:1351 / 1357
页数:7
相关论文
共 31 条
[1]   A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells [J].
Calimeri, T. ;
Battista, E. ;
Conforti, F. ;
Neri, P. ;
Di Martino, M. T. ;
Rossi, M. ;
Foresta, U. ;
Piro, E. ;
Ferrara, F. ;
Amorosi, A. ;
Bahlis, N. ;
Anderson, K. C. ;
Munshi, N. ;
Tagliaferri, P. ;
Causa, F. ;
Tassone, P. .
LEUKEMIA, 2011, 25 (04) :707-711
[2]   Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations [J].
Deng, Kai ;
Pertea, Mihaela ;
Rongvaux, Anthony ;
Wang, Leyao ;
Durand, Christine M. ;
Ghiaur, Gabriel ;
Lai, Jun ;
McHugh, Holly L. ;
Hao, Haiping ;
Zhang, Hao ;
Margolick, Joseph B. ;
Gurer, Cagan ;
Murphy, Andrew J. ;
Valenzuela, David M. ;
Yancopoulos, George D. ;
Deeks, Steven G. ;
Strowig, Till ;
Kumar, Priti ;
Siliciano, Janet D. ;
Salzberg, Steven L. ;
Flavell, Richard A. ;
Shan, Liang ;
Siliciano, Robert F. .
NATURE, 2015, 517 (7534) :381-U544
[3]   Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy [J].
Dhodapkar, Madhav V. ;
Sexton, Rachael ;
Das, Rituparna ;
Dhodapkar, Kavita M. ;
Zhang, Lin ;
Sundaram, Ranjini ;
Soni, Sonal ;
Crowley, John J. ;
Orlowski, Robert Z. ;
Barlogie, Bart .
BLOOD, 2015, 126 (22) :2475-2478
[4]   Immune Modulation in Hematologic Malignancies [J].
Dhodapkar, Madhav V. ;
Dhodapkar, Kavita M. .
SEMINARS IN ONCOLOGY, 2015, 42 (04) :617-625
[5]   Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120) [J].
Dhodapkar, Madhav V. ;
Sexton, Rachael ;
Waheed, Sarah ;
Usmani, Saad ;
Papanikolaou, Xenofon ;
Nair, Bijay ;
Petty, Nathan ;
Shaughnessy, John D., Jr. ;
Hoering, Antje ;
Crowley, John ;
Orlowski, Robert Z. ;
Barlogie, Bart .
BLOOD, 2014, 123 (01) :78-85
[6]   Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy [J].
Dhodapkar, MV ;
Krasovsky, J ;
Osman, K ;
Geller, MD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (11) :1753-1757
[7]   A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma [J].
Dhodapkar, MV ;
Geller, MD ;
Chang, DH ;
Shimizu, K ;
Fujii, SI ;
Dhodapkar, KM ;
Krasovsky, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1667-1676
[8]   Myeloma as a model for the process of metastasis: implications for therapy [J].
Ghobrial, Irene M. .
BLOOD, 2012, 120 (01) :20-30
[9]   Xenograft models for normal and malignant stem cells [J].
Goyama, Susumu ;
Wunderlich, Mark ;
Mulloy, James C. .
BLOOD, 2015, 125 (17) :2630-2640
[10]   Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation [J].
Hanamura, Ichiro ;
Stewart, James P. ;
Huang, Yongsheng ;
Zhan, Fenghuang ;
Santra, Madhumita ;
Sawyer, Jeffrey R. ;
Hollmig, Klaus ;
Zangarri, Maurizio ;
Pineda-Roman, Mauricio ;
van Rhee, Frits ;
Cavallo, Federica ;
Burington, Bart ;
Crowley, John ;
Tricot, Guido ;
Barlogie, Bart ;
Shaughnessy, John D., Jr. .
BLOOD, 2006, 108 (05) :1724-1732